Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms

BACKGROUND: Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA). CASE PRESENTATION: We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of the lite...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Rheumatol Online J
Autors principals: Halyabar, Olha, Friedman, Kevin G., Sundel, Robert P., Baker, Annette L., Chang, Margaret H., Gould, Patrick W., Newburger, Jane W., Son, Mary Beth F.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968156/
https://ncbi.nlm.nih.gov/pubmed/33731148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-021-00526-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars